Publications by authors named "Michael Buschle"

Claim this Profile
T
Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.
Christoph S Klade, Heiner Wedemeyer, Thomas Berg, Holger Hinrichsen, Grazyna Cholewinska, Michael Buschle

Gastroenterology· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals.
Juliane Schalich, Oresta Vytvytska, Wolfgang Zauner, Michael B Fischer, Michael Buschle

Biol Chem· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses.
Carola Schellack, Karin Prinz, Alena Egyed, Jörg H Fritz, Barbara Wittmann, Michael Buschle

Vaccine· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects.
Christa Firbas, Bernd Jilma, Erich Tauber, Vera Buerger, Sandra Jelovcan, Michael Buschle

Vaccine· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIBF (progesterone induced blocking factor) is overexpressed in highly proliferating cells and associated with the centrosome.
Margit Lachmann, Dieter Gelbmann, Endre Kálmán, Beata Polgár, Michael Buschle

Int J Cancer· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a TH2-type immune response to co-injected antigens.
Jörg H Fritz, Sylvia Brunner, Max L Birnstiel, Michael Buschle, Alexander v Gabain

Vaccine· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrovirus-mediated IL-7 expression in leukemic dendritic cells generated from primary acute myelogenous leukemias enhances their functional properties.
Concha Bello-Fernández, Jana Stasakova, Alexander Renner, Nicole Carballido-Perrig, Margit Koening, Michael Buschle

Blood· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dendritic cell-specific chemokine, dendritic cell-derived CC chemokine 1, enhances protective cell-mediated immunity to murine malaria.
Oscar Bruna-Romero, John Schmieg, Margarita Del Val, Michael Buschle, Moriya Tsuji

J Immunol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of specific immune responses by polycation-based vaccines.
Petra Lührs, Walter Schmidt, Raphaela Kutil, Michael Buschle, Stephan N Wagner

J Immunol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly-L-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-inflammatory cytokines.
Karen Lingnau, Alena Egyed, Carola Schellack, Frank Mattner, Michael Buschle

Vaccine· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Binding immune-stimulating oligonucleotides to cationic peptides from viral core antigen enhances their potency as adjuvants.
Petra Riedl, Michael Buschle, Jörg Reimann, Reinhold Schirmbeck

Eur J Immunol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus.
Hildegard Etz, Duc Bui Minh, Tamás Henics, Agnieszka Dryla, Birgit Winkler, Michael Buschle

Proc Natl Acad Sci U S A· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with poly-L-arginine as immunostimulant for peptide vaccines: induction of potent and long-lasting T-cell responses against cancer antigens.
Frank Mattner, Julia-Kristina Fleitmann, Karen Lingnau, Walter Schmidt, Alena Egyed, Michael Buschle

Cancer Res· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis